Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
Clinical trial NCT00072579 · COMPLETED
Trial details
- NCT number
- NCT00072579
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2006-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.